Sarcopenia and Peripheral Artery Disease With Chronic Limb Threatening Ischemia
SAC
Correlation of Sarcopenia and Peripheral Artery Disease With Chronic Limb Threatening Ischemia
1 other identifier
observational
97
1 country
1
Brief Summary
To evaluate the correlation of Sarcopenia Parameters and Peripheral Artery Disease with chronic limb threatening ischaemia.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jan 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2024
CompletedFirst Submitted
Initial submission to the registry
June 5, 2025
CompletedFirst Posted
Study publicly available on registry
June 26, 2025
CompletedJune 26, 2025
June 1, 2025
2 years
June 5, 2025
June 24, 2025
Conditions
Outcome Measures
Primary Outcomes (2)
psoas muscle area (PMA) [measured by computed tomography (CT)]
psoas muscle area (PMA) (square centimeters) was regarded as a kind of typical sarcopenia parameters, measured by computed tomography (CT) at the L3 vertebral level
2023.1.1~2024.12.31
total abdominal muscle area (TAMA) measured by computed tomography (CT)
total abdominal muscle area (TAMA) (square centimeters) was regarded as a kind of typical sarcopenia parameters, measured by computed tomography (CT) at the L3 vertebral level
2023.1.1~2024.12.31
Study Arms (1)
patiets with peripheral artery disease
Interventions
Eligibility Criteria
patients of Peripheral Artery Disease
You may qualify if:
- Patients of Peripheral Artery Disease, including intermittent claudication and Chronic Limb Threatening Ischemia;
- Patients with Rutherford grade 2-6 between Jan.1 2023 and Dec.31 2024;
- Patients at age 18-80;
- Patients underwent an in-hospital routine enhanced whole abdomen to lower extremities CT scan;
- Patients able to complete the clinical follow-up for 3 months.
You may not qualify if:
- Poor CT quality or incomplete images;
- Incomplete clinical data;
- In-hospital mortality during Jan.1 2023 and Dec.31 2024.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Fudan Universitylead
Study Sites (1)
Huadong Hospital, Fudan University
Shanghai, 200040, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Hospital director
Study Record Dates
First Submitted
June 5, 2025
First Posted
June 26, 2025
Study Start
January 1, 2023
Primary Completion
December 31, 2024
Study Completion
December 31, 2024
Last Updated
June 26, 2025
Record last verified: 2025-06